Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.65 - $1.25 $46,650 - $89,712
71,770 New
71,770 $58,000
Q2 2023

Aug 11, 2023

SELL
$0.81 - $1.15 $4,131 - $5,865
-5,100 Reduced 29.71%
12,067 $13,000
Q1 2023

May 16, 2023

SELL
$0.8 - $1.74 $3,270 - $7,113
-4,088 Reduced 19.23%
17,167 $14,000
Q4 2022

Feb 14, 2023

BUY
$1.09 - $20.4 $9,390 - $175,746
8,615 Added 68.16%
21,255 $27,000
Q3 2022

Nov 14, 2022

SELL
$1.7 - $20.52 $5,642 - $68,105
-3,319 Reduced 20.8%
12,640 $21,000
Q2 2022

Aug 15, 2022

SELL
$1.35 - $2.29 $37,278 - $63,236
-27,614 Reduced 63.37%
15,959 $34,000
Q1 2022

May 16, 2022

SELL
$1.46 - $2.45 $19,601 - $32,893
-13,426 Reduced 23.55%
43,573 $90,000
Q4 2021

Feb 14, 2022

BUY
$2.13 - $3.46 $44,955 - $73,026
21,106 Added 58.8%
56,999 $133,000
Q3 2021

Nov 15, 2021

SELL
$3.14 - $3.9 $140,028 - $173,920
-44,595 Reduced 55.41%
35,893 $125,000
Q2 2021

Aug 11, 2021

BUY
$3.8 - $4.56 $177,927 - $213,512
46,823 Added 139.09%
80,488 $312,000
Q1 2021

May 17, 2021

SELL
$4.33 - $6.63 $21,351 - $32,692
-4,931 Reduced 12.78%
33,665 $155,000
Q4 2020

Feb 16, 2021

SELL
$4.87 - $17.29 $34,581 - $122,776
-7,101 Reduced 15.54%
38,596 $234,000
Q3 2020

Nov 16, 2020

BUY
$15.08 - $27.04 $535,324 - $959,892
35,499 Added 348.1%
45,697 $751,000
Q1 2020

May 15, 2020

SELL
$10.27 - $21.23 $1.05 Million - $2.18 Million
-102,497 Reduced 90.95%
10,198 $151,000
Q3 2019

Nov 14, 2019

SELL
$9.83 - $14.82 $599,394 - $903,664
-60,976 Reduced 35.11%
112,695 $1.11 Million
Q2 2019

Aug 16, 2019

BUY
$12.9 - $20.8 $213,224 - $343,803
16,529 Added 10.52%
173,671 $2.34 Million
Q2 2019

Aug 14, 2019

BUY
$12.9 - $20.8 $1.36 Million - $2.2 Million
105,795 Added 206.04%
157,142 $2.12 Million
Q4 2018

Feb 14, 2019

SELL
$19.05 - $36.45 $731,615 - $1.4 Million
-38,405 Reduced 42.79%
51,347 $1.16 Million
Q3 2018

Nov 14, 2018

SELL
$34.41 - $44.23 $864,310 - $1.11 Million
-25,118 Reduced 21.87%
89,752 $3.33 Million
Q2 2018

Aug 14, 2018

BUY
$39.21 - $50.29 $1.77 Million - $2.26 Million
45,017 Added 64.45%
114,870 $4.5 Million
Q1 2018

May 15, 2018

BUY
$41.7 - $64.16 $1.79 Million - $2.76 Million
42,963 Added 159.77%
69,853 $3.43 Million
Q4 2017

Feb 14, 2018

SELL
$28.58 - $49.91 $462,567 - $807,793
-16,185 Reduced 37.57%
26,890 $1.22 Million
Q3 2017

Nov 20, 2017

BUY
$23.08 - $34.92 $994,170 - $1.5 Million
43,075
43,075 $1.5 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.